+

DK0666929T3 - Fremgangsmåde til inhibering af hyperproliferative cellers replikation - Google Patents

Fremgangsmåde til inhibering af hyperproliferative cellers replikation

Info

Publication number
DK0666929T3
DK0666929T3 DK93924312T DK93924312T DK0666929T3 DK 0666929 T3 DK0666929 T3 DK 0666929T3 DK 93924312 T DK93924312 T DK 93924312T DK 93924312 T DK93924312 T DK 93924312T DK 0666929 T3 DK0666929 T3 DK 0666929T3
Authority
DK
Denmark
Prior art keywords
hyperproliferative cells
hyperproliferative
polypeptide
relates
replication
Prior art date
Application number
DK93924312T
Other languages
Danish (da)
English (en)
Inventor
Steven M Frisch
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of DK0666929T3 publication Critical patent/DK0666929T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93924312T 1992-10-13 1993-10-13 Fremgangsmåde til inhibering af hyperproliferative cellers replikation DK0666929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/960,112 US5516631A (en) 1992-10-13 1992-10-13 Method of inhibiting replication of hyperproliferative cells
PCT/US1993/009774 WO1994009160A1 (fr) 1992-10-13 1993-10-13 Procede permettant d´inhiber la replication de cellules hyperproliferatives

Publications (1)

Publication Number Publication Date
DK0666929T3 true DK0666929T3 (da) 2003-09-15

Family

ID=25502805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93924312T DK0666929T3 (da) 1992-10-13 1993-10-13 Fremgangsmåde til inhibering af hyperproliferative cellers replikation

Country Status (10)

Country Link
US (2) US5516631A (fr)
EP (1) EP0666929B1 (fr)
JP (1) JP3492364B2 (fr)
AT (1) ATE240404T1 (fr)
CA (1) CA2147127A1 (fr)
DE (1) DE69332978T2 (fr)
DK (1) DK0666929T3 (fr)
ES (1) ES2194849T3 (fr)
PT (1) PT666929E (fr)
WO (1) WO1994009160A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5776743A (en) * 1994-09-06 1998-07-07 La Jolla Cancer Research Foundation Method of sensitizing tumor cells with adenovirus E1A
US6326356B1 (en) 1996-10-18 2001-12-04 Board Of Regents, The University Of Texas System Suppression of neu overexpression using a mini-E1A gene
US5869040A (en) * 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
WO1997005898A1 (fr) * 1995-08-03 1997-02-20 The Johns Hopkins University School Of Medicine Destruction de l'epithelium d'une glande exocrine dans le traitement prophilactique et therapeutique du cancer
US5763415A (en) 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
CA2317505C (fr) 1998-01-23 2011-01-04 Newbiotics, Inc. Agents therapeutiques obtenus par catalyse enzymatique
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
EP1200130A2 (fr) 1999-07-22 2002-05-02 Newbiotics, Inc. Procedes pour traiter les tumeurs resistantes aux therapies
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
US20040266834A1 (en) * 1999-10-14 2004-12-30 Copland John A. Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
US20040191761A1 (en) * 2003-03-27 2004-09-30 Routes John M. Modified adenoviral E1A constructs and methods of use thereof
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
WO2012071492A1 (fr) 2010-11-23 2012-05-31 Georgia Tech Research Corporation Membres de la famille mir-200 induisant la transition mésenchyme-épithélium dans le cancer des ovaires

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5651964A (en) * 1990-12-04 1997-07-29 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by the adenoviral EIA gene
US5641484A (en) * 1990-12-04 1997-06-24 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
PT931830E (pt) * 1993-02-16 2001-08-30 Onyx Pharma Inc Virus citopaticos para terapia e profilaxia de neoplasia

Also Published As

Publication number Publication date
WO1994009160A1 (fr) 1994-04-28
EP0666929B1 (fr) 2003-05-14
ATE240404T1 (de) 2003-05-15
JPH08504573A (ja) 1996-05-21
PT666929E (pt) 2003-08-29
CA2147127A1 (fr) 1994-04-28
DE69332978D1 (de) 2003-06-18
US5866550A (en) 1999-02-02
JP3492364B2 (ja) 2004-02-03
ES2194849T3 (es) 2003-12-01
DE69332978T2 (de) 2004-02-26
US5516631A (en) 1996-05-14
EP0666929A4 (fr) 1996-07-10
EP0666929A1 (fr) 1995-08-16

Similar Documents

Publication Publication Date Title
DK0666929T3 (da) Fremgangsmåde til inhibering af hyperproliferative cellers replikation
IE820069L (en) Recombinant dna encoding a polypeptide
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ES8600783A1 (es) Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
ES8800359A1 (es) Metodo de produccion de factor viii:c humano
ATE198621T1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
DK240088A (da) Fremgangsmaade til transformation af et plantecellematerale
DK0941349T3 (da) Fremgangsmåde til fremstilling af polypeptider i surfactinmutanter af Bacillusceller
EP1344819A3 (fr) Cellules souches hématopoiétiques humaines
DK62881A (da) Rekombinant-dna indeholdende et analysekodningsgen, genetisk konstruerede mikroorganismer med evne til massiv produktion af amylolytiske enzymer og fremgangsmaade til fremstilling af saadanne enzymer
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
AU7659298A (en) Recombinant lactoferrin, methods of production from plants and uses
EP0182448A3 (fr) Production de facteur VIII et produits apparentés
DK432987D0 (da) Fremgangsmaade til forbedring af ekspressionen af eukaryotprotein
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
DK358787A (da) Vaekstfaktor, nucleotidsekvens kodende for vaekstfaktoren ekspressionsplasmid omfattende nucleotidsekvensen,vaert indeholdende plasmidet protein fremstillet af vaerten, fremgangsmaade til fremstilling af vaekstfaktoren og farmaceutisk praeparat indeholdendevaekstfaktoren
DK619284D0 (da) Udtrykkelsesplasmid til forbedret produktion af heterologt protein ibakterier og fremgangsmaade til fremstilling af dette protein samtfremgangsmaade til fremstilling af plasmidet
DK0658626T3 (da) Fremgangsmåder til produktion af protein C
ATE236983T1 (de) Durch zelldichte stimulierte protein-tyrosin- phosphatasen
EP1127104A4 (fr) Technique de culture massive de cellules produisant de l'erythropoietine humaine de recombinaison
PT1007647E (pt) Expressao de ingap em niveis elevados
ES8800723A1 (es) Un metodo para preparar renina humana.
ATE322540T1 (de) Zubereitung für übertragung der aktive tumorspezifische immunisierung von einem immunisiertem allogenem knochenmarkspender
DK577283D0 (da) Gen kodet for interleukin-2-polypeptid,rekombinant dna baerende dette gen,levende cellelinie indeholdende dette rekombinante dna og fremgangsmaade til fremstilling af interleukin-2 ved anvendelse af denne cellelinie
SE8901715L (sv) En plasmid dna-konstruktion innehaallande dna-sekvenser
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载